Filipa Santos

Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial

Alasdair Munro, Shuo Feng, Leila Janani et al. · The Lancet Infectious Diseases · 2022 · 177 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +16

Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis

Joel M. Dulhunty, Stephen J. Brett, Jan J. De Waele et al. · JAMA · 2024 · 139 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial

Simin Florescu, Delia Stanciu, Mihaela Zaharia et al. · JAMA · 2022 · 137 citations · Full text

Medicine, Critical Care Nursing, Critical Care Medicine +6

Genomic differentiation among wild cyanophages despite widespread horizontal gene transfer

Ann Gregory, Sergei A. Solonenko, J. Cesar Ignacio‐Espinoza et al. · BMC Genomics · 2016 · 123 citations · Full text

Life Sciences, Genetics, Microbiology +17

25th Annual Computational Neuroscience Meeting: CNS-2016

Tatyana O. Sharpee, Alain Destexhe, Mitsuo Kawato et al. · BMC Neuroscience · 2016 · 101 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17